Micronized placental tissue compositions and methods of making and using the same

US11103536B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11103536-B2
Application numberUS-201916520909-A
CountryUS
Kind codeB2
Filing dateJul 24, 2019
Priority dateFeb 14, 2011
Publication dateAug 31, 2021
Grant dateAug 31, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are compositions composed of micronized placental components and pharmaceutical compositions thereof. The compositions have numerous medical applications. Methods for making and using the micronized compositions are also described herein.

First claim

Opening claim text (preview).

What is claimed: 1. A method for promoting wound healing, wherein the method comprises contacting a wound with a composition comprising micronized placental tissue particles, said tissue particles consisting essentially of an amnion layer and a chorion layer, wherein the chorion layer is layered directly over the amnion layer, wherein the intermediate layer has been substantially removed, wherein the amnion layer has an epithelial layer and an exposed fibroblast layer, and further wherein the wound healing is associated with an orthopedic application. 2. The method of claim 1 , wherein the orthopedic application is selected from the group consisting of tendon repair, aiding in the repair of periosteum, repair of ruptured/damaged bursa, securing void filling materials during bone repair, repair of an articular surface, repair of a soft-tissue injury in or around a joint, application to an articular surface, repair and/or regrow chondrocytes, and as an anti-adhesion barrier. 3. The method of claim 2 , wherein the soft-tissue injury is caused by trauma or repeated motion. 4. The method of claim 1 , wherein the micronized placental tissue particles are dehydrated. 5. The method of claim 1 , wherein the composition is an injectable composition. 6. The method of claim 1 , wherein the micronized placental tissue particles are less than 500 μm. 7. The method of claim 6 , wherein the micronized placental tissue particles are less than 300 μm. 8. The method of claim 7 , wherein the micronized placental tissue particles are 25-150 μm.

Assignees

Inventors

Classifications

  • characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel · CPC title

  • Flowable or injectable implant compositions · CPC title

  • for soft tissue reconstruction · CPC title

  • characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this (A61L27/3687, A61L27/3691 take precedence) · CPC title

  • for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11103536B2 cover?
Described herein are compositions composed of micronized placental components and pharmaceutical compositions thereof. The compositions have numerous medical applications. Methods for making and using the micronized compositions are also described herein.
Who is the assignee on this patent?
Mimedx Group Inc
What technology area does this patent fall under?
Primary CPC classification A61K35/50. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).